RS20100123A - Azaindoli - Google Patents

Azaindoli

Info

Publication number
RS20100123A
RS20100123A RSP-2010/0123A RSP20100123A RS20100123A RS 20100123 A RS20100123 A RS 20100123A RS P20100123 A RSP20100123 A RS P20100123A RS 20100123 A RS20100123 A RS 20100123A
Authority
RS
Serbia
Prior art keywords
compound according
aryl
optionally substituted
alkyl
pyrrolo
Prior art date
Application number
RSP-2010/0123A
Other languages
English (en)
Serbian (sr)
Inventor
Paul Joseph Cox
Tahir Nadeem Majid
Justine Yeun Quai Lai
Andrew David Morley
Shelley Amendola
Stephanie Deprets
Chris Edlin
Original Assignee
Aventis-Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis-Pharma Limited filed Critical Aventis-Pharma Limited
Publication of RS20100123A publication Critical patent/RS20100123A/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RSP-2010/0123A 1999-12-24 2000-12-27 Azaindoli RS20100123A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930698.7A GB9930698D0 (en) 1999-12-24 1999-12-24 Chemical compounds
US21581800P 2000-07-05 2000-07-05

Publications (1)

Publication Number Publication Date
RS20100123A true RS20100123A (sr) 2010-12-31

Family

ID=10867079

Family Applications (2)

Application Number Title Priority Date Filing Date
RSP-2010/0123A RS20100123A (sr) 1999-12-24 2000-12-27 Azaindoli
YUP-462/02A RS51303B (sr) 1999-12-24 2000-12-27 Azaindoli

Family Applications After (1)

Application Number Title Priority Date Filing Date
YUP-462/02A RS51303B (sr) 1999-12-24 2000-12-27 Azaindoli

Country Status (12)

Country Link
JP (1) JP4871474B2 (de)
AT (2) ATE480537T1 (de)
DE (1) DE60044946D1 (de)
DK (2) DK1263759T3 (de)
ES (2) ES2382759T3 (de)
GB (1) GB9930698D0 (de)
ME (1) MEP49908A (de)
PL (1) PL218884B1 (de)
PT (2) PT1263759E (de)
RS (2) RS20100123A (de)
UA (1) UA76410C2 (de)
ZA (1) ZA200204126B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422057D0 (en) * 2004-10-05 2004-11-03 Astrazeneca Ab Novel compounds
EA200870117A1 (ru) * 2005-12-23 2008-12-30 Смитклайн Бичам Корпорейшн Азаиндоловые ингибиторы аурора-киназ
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
JP5274805B2 (ja) * 2006-09-20 2013-08-28 三菱化学株式会社 フッ素化芳香族化合物の製造方法
EP2373653B1 (de) * 2008-12-05 2014-04-02 F. Hoffmann-La Roche AG Pyrrolopyrazinyl-harnstoff kinase-inhibitoren
US8816085B2 (en) * 2009-08-26 2014-08-26 Takeda Gmbh Methylpyrrolopyridinecarboxamides
US9796708B2 (en) * 2013-03-14 2017-10-24 Abbvie Inc. Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000057137A (ko) * 1996-11-19 2000-09-15 스티븐 엠. 오드레 아릴 및 헤테로아릴로 치환된 융합 피롤 항염증제
WO1998047899A1 (en) * 1997-04-24 1998-10-29 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
BR9812944A (pt) * 1997-10-20 2000-08-08 Hoffmann La Roche Inibidores bicìclicos da cinase

Also Published As

Publication number Publication date
PL218884B1 (pl) 2015-02-27
MEP49908A (en) 2011-02-10
UA76410C2 (en) 2006-08-15
ZA200204126B (en) 2003-08-25
PT1990343E (pt) 2012-05-22
DK1990343T3 (da) 2012-07-23
ATE480537T1 (de) 2010-09-15
ES2382759T3 (es) 2012-06-13
DE60044946D1 (de) 2010-10-21
RS51303B (sr) 2010-12-31
PT1263759E (pt) 2010-11-02
ATE552258T1 (de) 2012-04-15
ES2348861T3 (es) 2010-12-16
JP2003519144A (ja) 2003-06-17
JP4871474B2 (ja) 2012-02-08
DK1263759T3 (da) 2011-01-10
YU46202A (sh) 2005-06-10
GB9930698D0 (en) 2000-02-16

Similar Documents

Publication Publication Date Title
US6770643B2 (en) Azaindoles
KR100915289B1 (ko) 아자인돌
RS20100123A (sr) Azaindoli